Enzo Biochem, Inc.
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates throu…
Insiders
Transactions
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
|
$380,412
d
cs
10% Holder
|
07/24/24 |
F
|
70,885 x $1.17 = $82,935.45 |
Footnotes
#1 On August 31, 2023, the Reporting Person was granted, as previously reported on Form 4, 215,210 Restricted Stock Units ("RSUs"), which vested on July 24, 2024. 70,885 shares of common stock were withheld by Enzo Biochem, Inc. to satisfy tax withholding requirements in connection with the vesting of such RSUs.
|
|||
|
$451,297
d
cs
10% Holder
|
02/23/24 |
A
|
150,000 x $0 = $0 |
Footnotes
#1 Represents shares issued, on February 21, 2024, for no consideration pursuant to a Performance Share Award that vested in full on November 3, 2023.
#2 Represents shares withheld by Enzo Biochem, Inc. upon the issuance of the shares described in Footnote 1 above to satisfy tax withholding requirements.
#3 The Reporting Person was granted Restricted Stock Units that will fully vest, subject to the individual's continued employment with Enzo Biochem, Inc, in three equal annual installments over the course of three years, commencing on the first anniversary of the grant date; provided, that, they shall vest in full earlier upon the occurrence of a Change of Control.
|
|||
|
$307,120
d
cs
10% Holder
|
02/21/24 |
M
|
10,640 x $0 = $0 |
Footnotes
#1 Represents shares issued, on February 21, 2024, for no consideration pursuant to a Performance Share Award that vested in full on November 3, 2023.
#2 Represents shares withheld by Enzo Biochem, Inc. upon the issuance of the shares described in Footnote 1 above to satisfy tax withholding requirements.
#3 The Reporting Person was granted Restricted Stock Units that will fully vest, subject to the individual's continued employment with Enzo Biochem, Inc, in three equal annual installments over the course of three years, commencing on the first anniversary of the grant date; provided, that, they shall vest in full earlier upon the occurrence of a Change of Control.
|
|||
|
$301,297
d
cs
10% Holder
|
02/21/24 |
F
|
5,823 x $0 = $0 |
Footnotes
#1 Represents shares issued, on February 21, 2024, for no consideration pursuant to a Performance Share Award that vested in full on November 3, 2023.
#2 Represents shares withheld by Enzo Biochem, Inc. upon the issuance of the shares described in Footnote 1 above to satisfy tax withholding requirements.
#3 The Reporting Person was granted Restricted Stock Units that will fully vest, subject to the individual's continued employment with Enzo Biochem, Inc, in three equal annual installments over the course of three years, commencing on the first anniversary of the grant date; provided, that, they shall vest in full earlier upon the occurrence of a Change of Control.
|
|||
|
$4,390,882
d
cs
10% Holder
|
01/31/24 |
A
|
79,365 x $0 = $0 |
Footnotes
#1 The Reporting Person was granted Restricted Stock Units that will fully vest upon the earlier of: (i) the first anniversary of the grant date (i.e., January 31, 2025), or (ii) a change of control event.
|
|||
Get PRO Today
With PRO you will unlock 28 more insider transactions for Enzo Biochem, Inc.
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: